89 related articles for article (PubMed ID: 18498869)
1. A pilot study of perillyl alcohol in pancreatic cancer.
Matos JM; Schmidt CM; Thomas HJ; Cummings OW; Wiebke EA; Madura JA; Patrick LJ; Crowell PL
J Surg Res; 2008 Jun; 147(2):194-9. PubMed ID: 18498869
[TBL] [Abstract][Full Text] [Related]
2. Induction of the apoptosis-promoting protein Bak by perillyl alcohol in pancreatic ductal adenocarcinoma relative to untransformed ductal epithelial cells.
Stayrook KR; McKinzie JH; Burke YD; Burke YA; Crowell PL
Carcinogenesis; 1997 Aug; 18(8):1655-8. PubMed ID: 9276644
[TBL] [Abstract][Full Text] [Related]
3. Effects of the isoprenoids perillyl alcohol and farnesol on apoptosis biomarkers in pancreatic cancer chemoprevention.
Burke YD; Ayoubi AS; Werner SR; McFarland BC; Heilman DK; Ruggeri BA; Crowell PL
Anticancer Res; 2002; 22(6A):3127-34. PubMed ID: 12530055
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol.
Stark MJ; Burke YD; McKinzie JH; Ayoubi AS; Crowell PL
Cancer Lett; 1995 Sep; 96(1):15-21. PubMed ID: 7553603
[TBL] [Abstract][Full Text] [Related]
5. Effects of the antitumor agent perillyl alcohol on H-Ras vs. K-Ras farnesylation and signal transduction in pancreatic cells.
Stayrook KR; McKinzie JH; Barbhaiya LH; Crowell PL
Anticancer Res; 1998; 18(2A):823-8. PubMed ID: 9615726
[TBL] [Abstract][Full Text] [Related]
6. Perillyl alcohol inhibits a calcium-dependent constitutive nuclear factor-kappaB pathway.
Berchtold CM; Chen KS; Miyamoto S; Gould MN
Cancer Res; 2005 Sep; 65(18):8558-66. PubMed ID: 16166337
[TBL] [Abstract][Full Text] [Related]
7. Antitumorigenic effects of limonene and perillyl alcohol against pancreatic and breast cancer.
Crowell PL; Siar Ayoubi A; Burke YD
Adv Exp Med Biol; 1996; 401():131-6. PubMed ID: 8886131
[TBL] [Abstract][Full Text] [Related]
8. A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia.
Stearns V; Coop A; Singh B; Gallagher A; Yamauchi H; Lieberman R; Pennanen M; Trock B; Hayes DF; Ellis MJ
Clin Cancer Res; 2004 Nov; 10(22):7583-91. PubMed ID: 15569989
[TBL] [Abstract][Full Text] [Related]
9. A phase I trial of perillyl alcohol in patients with advanced solid tumors.
Azzoli CG; Miller VA; Ng KK; Krug LM; Spriggs DR; Tong WP; Riedel ER; Kris MG
Cancer Chemother Pharmacol; 2003 Jun; 51(6):493-8. PubMed ID: 12695855
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of colon carcinogenesis by dietary perillyl alcohol.
Reddy BS; Wang CX; Samaha H; Lubet R; Steele VE; Kelloff GJ; Rao CV
Cancer Res; 1997 Feb; 57(3):420-5. PubMed ID: 9012468
[TBL] [Abstract][Full Text] [Related]
11. Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy.
Kashiwagi H; McDunn JE; Simon PO; Goedegebuure PS; Xu J; Jones L; Chang K; Johnston F; Trinkaus K; Hotchkiss RS; Mach RH; Hawkins WG
Mol Cancer; 2007 Jul; 6():48. PubMed ID: 17631687
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol.
Burke YD; Stark MJ; Roach SL; Sen SE; Crowell PL
Lipids; 1997 Feb; 32(2):151-6. PubMed ID: 9075204
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21(Cip1) and p27(Kip1) in human pancreatic adenocarcinoma cells.
Wiseman DA; Werner SR; Crowell PL
J Pharmacol Exp Ther; 2007 Mar; 320(3):1163-70. PubMed ID: 17138864
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer.
Meadows SM; Mulkerin D; Berlin J; Bailey H; Kolesar J; Warren D; Thomas JP
Int J Gastrointest Cancer; 2002; 32(2-3):125-8. PubMed ID: 12794248
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer.
Bailey HH; Attia S; Love RR; Fass T; Chappell R; Tutsch K; Harris L; Jumonville A; Hansen R; Shapiro GR; Stewart JA
Cancer Chemother Pharmacol; 2008 Jun; 62(1):149-57. PubMed ID: 17885756
[TBL] [Abstract][Full Text] [Related]
16. Perillyl alcohol: applications in oncology.
Belanger JT
Altern Med Rev; 1998 Dec; 3(6):448-57. PubMed ID: 9855569
[TBL] [Abstract][Full Text] [Related]
17. Perillyl alcohol induces apoptosis in human glioblastoma multiforme cells.
Fernandes J; da Fonseca CO; Teixeira A; Gattass CR
Oncol Rep; 2005 May; 13(5):943-7. PubMed ID: 15809762
[TBL] [Abstract][Full Text] [Related]
18. Trofosfamide in patients with pancreatic cancer.
Schmidt-Sandte W; Dageförde J; Klapdor R; Wagner T; Wiedemann GJ
Anticancer Res; 1999; 19(4A):2485-7. PubMed ID: 10470179
[TBL] [Abstract][Full Text] [Related]
19. Serum CA 19-9 response to neoadjuvant therapy is associated with outcome in pancreatic adenocarcinoma.
Boone BA; Steve J; Zenati MS; Hogg ME; Singhi AD; Bartlett DL; Zureikat AH; Bahary N; Zeh HJ
Ann Surg Oncol; 2014 Dec; 21(13):4351-8. PubMed ID: 25092157
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of perillyl alcohol (NSC 641066) administered daily in patients with metastatic androgen independent prostate cancer.
Liu G; Oettel K; Bailey H; Ummersen LV; Tutsch K; Staab MJ; Horvath D; Alberti D; Arzoomanian R; Rezazadeh H; McGovern J; Robinson E; DeMets D; Wilding G
Invest New Drugs; 2003 Aug; 21(3):367-72. PubMed ID: 14578686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
